All In MedTech

Device Trial Radar · NCT02279979

Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

Last checked: Nov 20, 2026Latest source record: Jul 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

9

Actual

Start

Oct 2014

Primary completion

Jan 2017

Study completion Jan 2017

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
Collaborators
Thoratec Corporation
First posted
Oct 31, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to assess reasonable safety and performance of the HeartMate PHP to provide hemodynamic support for up to 72 hours in patients with cardiogenic shock requiring stabilization.

Conditions

  • Cardiogenic Shock

Interventions

  • HeartMate PHPDevice

    The HeartMate PHP system is a catheter-based heart pump and console designed to provide hemodynamic left ventricular support for up to 3 days to stabilize patients by maintaining adequate systemic cardiac output.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical stabilization defined as improvement of Cardiac Index to > 2.2 L/min/m2Time frame: 72 hours

Locations

6 sites in 4 countries. Site status is shown where the registry gives one.

  • Na Homolce Hospital

    Prague, Czechia

  • Institute for Clinical and Experimental Medicine (IKEM)

    Prague, Czechia

  • Universitätskliniken Düsseldorf

    Düsseldorf, Germany

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.